349 related articles for article (PubMed ID: 25591721)
1. High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia.
Omrani AS; Alfahad WA; Shoukri MM; Baadani AM; Aldalbahi S; Almitwazi AA; Albarrak AM
Ann Clin Microbiol Antimicrob; 2015 Jan; 14():3. PubMed ID: 25591721
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
[TBL] [Abstract][Full Text] [Related]
3. Association between colistin dose and development of nephrotoxicity.
Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
[TBL] [Abstract][Full Text] [Related]
4. Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study.
Phe K; Shields RK; Tverdek FP; Aitken SL; Guervil DJ; Lam WM; Musgrove RJ; Luce AM; Tam VH
J Antimicrob Chemother; 2016 Dec; 71(12):3585-3587. PubMed ID: 27543655
[TBL] [Abstract][Full Text] [Related]
5. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
[TBL] [Abstract][Full Text] [Related]
6. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.
Ozel AS; Ergönül Ö; Korten V
J Infect Dev Ctries; 2019 Oct; 13(10):877-885. PubMed ID: 32084017
[TBL] [Abstract][Full Text] [Related]
7. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of intravenous colistin: a prospective evaluation.
Falagas ME; Fragoulis KN; Kasiakou SK; Sermaidis GJ; Michalopoulos A
Int J Antimicrob Agents; 2005 Dec; 26(6):504-7. PubMed ID: 16280245
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
[TBL] [Abstract][Full Text] [Related]
11. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
Horcajada JP; Sorlí L; Luque S; Benito N; Segura C; Campillo N; Montero M; Esteve E; Mirelis B; Pomar V; Cuquet J; Martí C; Garro P; Grau S
Int J Antimicrob Agents; 2016 Dec; 48(6):725-727. PubMed ID: 28128096
[TBL] [Abstract][Full Text] [Related]
12. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes.
Kwon KH; Oh JY; Yoon YS; Jeong YJ; Kim KS; Shin SJ; Chung JW; Huh HJ; Chae SL; Park SY
Int J Antimicrob Agents; 2015 Jun; 45(6):605-9. PubMed ID: 25772644
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
Aggarwal R; Dewan A
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
[TBL] [Abstract][Full Text] [Related]
14. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.
Pogue JM; Lee J; Marchaim D; Yee V; Zhao JJ; Chopra T; Lephart P; Kaye KS
Clin Infect Dis; 2011 Nov; 53(9):879-84. PubMed ID: 21900484
[TBL] [Abstract][Full Text] [Related]
15. Colistin nephrotoxicity increases with age.
Balkan II; Dogan M; Durdu B; Batirel A; Hakyemez IN; Cetin B; Karabay O; Gonen I; Ozkan AS; Uzun S; Demirkol ME; Akbas S; Kacmaz AB; Aras S; Mert A; Tabak F
Scand J Infect Dis; 2014 Oct; 46(10):678-85. PubMed ID: 25073536
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity associated with intravenous colistin in critically ill patients.
Doshi NM; Mount KL; Murphy CV
Pharmacotherapy; 2011 Dec; 31(12):1257-64. PubMed ID: 22122186
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium.
Hassan MM; Gaifer Z; Al-Zakwani IS
Int J Clin Pharm; 2018 Apr; 40(2):444-449. PubMed ID: 29542034
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series.
Trifi A; Abdellatif S; Daly F; Mahjoub K; Nasri R; Oueslati M; Mannai R; Bouzidi M; Ben Lakhal S
Chemotherapy; 2016; 61(4):190-6. PubMed ID: 26863534
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
[TBL] [Abstract][Full Text] [Related]
20. Colistin-induced Nephrotoxicity in a Tertiary Teaching Hospital.
Al-Abdulkarim DA; Alzuwayed OA; Al Ammari M; Al Halwan S; Al Maklafi N; Thomas A
Saudi J Kidney Dis Transpl; 2020; 31(5):1057-1061. PubMed ID: 33229769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
